انڈیاناپولس کی زندگی

BioCrossroads Drives Collaboration and Growth in Indiana’s Life Sciences Sector

Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

صحت

Prevention Matters: A Long-Term Strategy to Stop Substance Use and Save Lives

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. The opioid epidemic was recently declared a national public health emergency – and for good reason.  In Indiana, an adult is now more likely to die from a drug overdose than a motor vehicle accident. But opioids aren’t the only substances fueling […]

READ MORE
صحت

Expanding Access to MAT in Prisons and Jails is Necessary for Combating the Opioid Epidemic

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. In 2017, more than 1,700 people died of a drug overdose in Indiana—an all-time high. This surge in overdose deaths has been driven by opioids, which now account for more than 80% of overdose deaths. Along with effective substance use prevention and harm […]

READ MORE